Real-world evidence for improved outcomes with histamine antagonists and aspirin in 22,560 COVID-19 patients

• Cameron Mura,
• Saskia Preissner,
• Susanne Nahles,
• Max Heiland,
• Philip E. Bourne,
• Robert Preissner

Affiliations

Cameron Mura

School of Data Science and Department of Biomedical Engineering, University of Virginia

Saskia Preissner

Department Oral and Maxillofacial Surgery, Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health

Susanne Nahles

Department Oral and Maxillofacial Surgery, Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health

Max Heiland

Department Oral and Maxillofacial Surgery, Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health

Philip E. Bourne

School of Data Science and Department of Biomedical Engineering, University of Virginia

Robert Preissner

Institute of Physiology and Science-IT, Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health